Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.
Liberty University
7 followers
Dyno Therapeutics
4 followers
Cellares
4 followers
Gilead Sciences
170 followers
Regeneron
142 followers
Illumina
81 followers
Agilent Technologies
88 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
48 followers
GRAIL
30 followers
Springside Chestnut Hill Academy
35 followers
Explore companies